Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postoperative Outcomes and Risk Profiles in Dual Liver-Lung Transplantation: A Single-Center Retrospective Analysis.

Journal of transplantation·2026
Same author

Successful Implementation of a Multidisciplinary Weight Loss Program Including GLP1 Receptor Agonists for Liver Transplant Candidates With High Body Mass Index.

Transplantation·2024
Same author

Digesting Digital Health: A Study of Appropriateness and Readability of ChatGPT-Generated Gastroenterological Information.

Clinical and translational gastroenterology·2024
Same author

Acute onset nitrofurantoin-induced autoimmune hepatitis after urinary tract infection treatment.

Clinical case reports·2024
Same author

Clinical characteristics of new-onset diabetes after liver transplantation and outcomes.

Annals of gastroenterological surgery·2024
Same author

Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.

Transplantation·2024

Related Experiment Video

Updated: Jun 12, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

Hepatorenal syndrome.

Deepak Venkat1, K K Venkat

  • 1Department of Internal Medicine, Ohio State University Medical Center, Columbus, OH 43210, USA. deepak.venkat@osumc.edu

Southern Medical Journal
|June 10, 2010
PubMed
Summary

Acute kidney injury (AKI) in end-stage liver disease (ESLD) is often hepatorenal syndrome (HRS). Prompt treatment of spontaneous bacterial peritonitis (SBP) and supportive care can prevent HRS, but liver transplantation remains the only definitive cure.

Area of Science:

  • Nephrology
  • Hepatology
  • Gastroenterology

Background:

  • Acute kidney injury (AKI) is a serious complication of end-stage liver disease (ESLD).
  • Hepatorenal syndrome (HRS) is a functional AKI caused by splanchnic vasodilation and reduced effective arterial volume in ESLD.
  • Spontaneous bacterial peritonitis (SBP) frequently precipitates HRS in ESLD patients.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and management of AKI secondary to HRS in ESLD.
  • To emphasize the importance of ruling out other causes of AKI and prompt SBP treatment.
  • To highlight the role of liver transplantation as the definitive treatment for HRS.

Main Methods:

  • Literature review of AKI in ESLD, focusing on HRS.
  • Discussion of diagnostic criteria for HRS, emphasizing exclusion of other AKI causes.

Related Experiment Videos

Last Updated: Jun 12, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
08:50

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat

Published on: July 3, 2013

  • Overview of current management strategies, including SBP treatment and supportive therapies.

    • Main Results:

    • HRS is a diagnosis of exclusion, requiring careful differentiation from other AKI types like prerenal azotemia.
    • Early antibiotic and albumin therapy for SBP significantly reduces the risk of developing HRS.
    • Intravenous albumin, vasoconstrictors, and renal replacement therapy serve as temporary measures, bridging patients to transplantation.

    Conclusions:

    • Liver transplantation is the only definitive treatment to improve long-term outcomes for patients with HRS.
    • Multidisciplinary collaboration among hospitalists, hepatologists, and nephrologists is crucial for optimal patient management.
    • Preventing and promptly treating SBP is key in mitigating HRS development in ESLD patients.